The Control of tPA and PAI-1 Secretion from the Vessel Wall

Pearson JD . Endothelial cell biology. Radiology 1991; 179: 9–14.

Vane JR Änggard EE Botting RM . Regulatory function of the vascular endothelium. N Engl J Med 1990; 323: 27–36.

Bronze GJ . Endothelial injury, coagulation and atherosclerosis. Coronary Artery Dis 1991; 2: 131–40.

Esmon CT . Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 1993; 9: 1–26.

Collen D Lijnen HR . Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114–24.

Sprengers ED Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381–87.

Aznar J Estelles A Gilabert J eds. Fibrinolytic inhibitors: Cellular, biological and clinical aspects. Madrid: Editorial Garsi, 1994.

Belin D. Biology and facultative secretion of plasminogen activator inhibitor-2. Thromb Haemost 1993; 70: 144–47.

Cunningham DD Pulliam L Vaughan PJ . Protease nexin-1 and thrombin: Injury-related processes in the brain. Thromb Haemost 1993; 70: 168–71.

Wun T-C Capuano A. Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem 1985; 260: 5061–66.

Wun T-C Capuano A. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. Blood 1987; 69: 1354–62.

Gurevich V. Pro-urokinase: Physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action. Semin Thromb Haemost 1988; 14: 110–15.

Blasi F Conese M Møller LB The urokinase receptor: Structure, regulation, and inhibito-mediated internalization. Fibrinolysis 1994; 8 (suppl 1): 182–88.

Danø K Behrendt N Brünner N Ellis V Ploug M Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8 (suppl 1): 189–203.

Bacharach E Itin A Keshet E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 1992; 89: 10686–90.

Kluft C Dooijewaard G Emeis JJ . Role of the contact system in fibrinolysis. Semin Thromb Haemost 1987; 13: 50–68.

Carmeliet P Schoonjans L Kieckens L Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419–24.

Carmeliet P Collen D. Evaluation of the plasminogen/plasmin system in transgenic mice. Fibrinolysis 1994; 8: (suppl 1): 269–75.

Brommer EJP . The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards. Thromb Res 1984; 34: 109–15.

Zamarron C Lijnen HR Collen D. Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro. Thromb Res 1984; 35: 335–45.

Fox KAA Robison AK Knabb RM Rosamond TL Sobel BE Bergmann SR . Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation 1985; 72: 1346–54.

Chandler WL Trimble SL Loo S-C Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (tPA) and t-PA/PAI-1 complex in plasma. Blood 1990; 76: 930–37.

Booth NA Simpson AJ Croll A Bennett B MacGregor IR . Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988; 70: 327–33.

Carmeliet P Stassen JM Schoonjans L Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis and thrombolysis. J Clin Invest 1993; 92: 2756–60.

Erickson LA Fici GJ Lund JE Boyle TP Polites HG Marotti KR . Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 1990; 346: 74–76.

Schleef RR Higgins DL Pillemer E Levitt JJ . Bleeding diathesis due to decreased functional activity of type-1 plasminogen activator inhibitor. J Clin Invest 1989; 83: 1747–52.

Dieval J Nguyen G Gross S Delobel J Kruithof EKO . A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type-1. Blood 1991; 77: 528–32.

Fay WP Shapiro AD Shih JL Schleef RR Ginsburg D. Complete deficiency of plasminogen activator inhibitor type-1 due to a frameshift mutation. N Engl J Med 1992; 327: 1729–33.

Reilly CF Fujita T Hutzelmann JE Mayer EJ Shebuski RJ . Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism. Circulation 1991; 84: 287–92.

Levi M Biemond BJ van Zonneveld AJ ten Cate JW Pannekoek H. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 1992; 85: 305–12.

Chandler WL . A kinetic model of the circulatory regulation of tissue plasminogen activator. Thromb Haemost 1990; 66: 321–28.

Chandler WL Levy WC Veith RC Stratton JR . A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training. Blood 1993; 81: 3293–302.

Rånby M Sundell B Nilsson TK . Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 1989; 62: 917–22.

Philips M Juul A-G Selmer J Lind B Thorsen S. A specific immunologic assay for functional plasminogen activator inhibitor in plasma – standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease. Thromb Haemost 1992; 68: 486–94.

Chandler WL Stratton JR . Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction. Am J Clin Pathol 1994; 102: 248–52.

Brommer EJP Derkx FHM Schalekamp MADH Doooijewaard G van der Klaauw MM . Renal and hepatic handling of endogenous tissue-type plasminogen activator (tPA) and its inhibitor in man. Thromb Haemost 1988; 59: 404–11.

Nguyen H Berleau L Modi N Bennett WF Keyt BA . Formation of tPA:PAI₁ complex does not mediate rapid clearance of physiologic levels of tPA in vivo [Abstract], Fibrinolysis 1994; 8 (suppl 1): 7.

Jansson JH Nilsson TK Olofsson BO . Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J 1991; 12: 157–61.

Jansson JH Olofsson BO Nilsson TK . Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 1993; 88: 2030–34.

Ridker PM Vaughan DE Stampfer MJ Manson JE Hennekens CH . Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165–68.

Ridker PM Hennekens CH Stampfer MJ Manson JE Vaughan DE . Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940–43.

Meade TW Howarth DJ Cooper J MacCallum PK Stirling Y. Fibrinolytic activity and arterial disease [Letter]. Lancet 1994; 343: 1442.

Mayer EJ Fujita T Gardell SJ Shebuski RJ Reilly CF . The pharmacokinetics of plasminogen activator inhibitor-1 in the rabbit. Blood 1990; 76: 1514–20.

Fearns C Samad F Loskutoff DJ . Synthesis and localization of PAI-1 in the vessel wall. In: Van Hinsbergh VWM ed. Vascular control of haemostasis. Camberwell, Australia: Gordon and Breach, 1995 (in press).

Padró T Quax PHA van den Hoogen CM Roholl P Verheijen J Emeis JJ . Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. Arterioscler Thromb 1994; 14: 1459–65.

Todd AS . Fibrinolysis autographs. Nature 1958; 181: 495–96.

Todd AS . Localization of fibrinolytic activity in tissues. Br Med Bull 1964; 20: 210–12.

Todd AS . Endothelium and fibrinolysis. Bibl Anat 1972; 12: 98–105.

Rijken DC Wijngaards G Welbergen J. Relationship between tissue plasminogen activator and the activator in blood and vascular wall. Thromb Res 1980; 18: 815–30.

Kristensen P Larsson L-I Nielsen LS Grøndahl-Hansen J Andreasen PA Danø K. Human endothelial cells contain one type of plasminogen activator. FEBS Lett 1984; 168: 33–37.

Kristensen P. Localization of components from the plasminogen activation system in mammalian tissues. Acta Pathol Microbiol Immunol Scand 1992; 100 (suppl 29): 1–27.

Levin EG del Zoppo GJ . Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 1994; 144: 855–61.

Warren BA . Fibrinolytic activity of vascular endothelium. Br Med Bull 1964; 20: 213–16.

Pandolfi M Nilsson IM Robertson B Isacson S. Fibrinolytic activity of human veins. Lancet 1967; ii: 127–28.

Browse NL Gray L Jarrett PEM Morland M. Blood and vein wall fibrinolytic activity in health and vascular disease. Br Med J 1977, 1: 478–81.

Hecht Noordhoek V. Relations between activation and inhibition of fibrinolysis in the walls of human arteries and veins. Thromb Haemost 1977; 38: 407–19.

Kwaan HC Astrup T. Fibrinolytic activity in human atherosclerotic coronary arteries. Circ Res 1967; 21: 799–804.

Fischer S. Fibrinolytic activity in human coronary arteries. Review and quantitative studies. Adv Cardiol 1970; 4: 187–210.

Underwood MJ De Bono DP . Increased fibrinolytic activity in the intima of atheromatous coronary arteries: Protection at a price. Cardiovasc Res 1993; 27: 882–85.

Isacson S. Low fibrinolytic activity of blood and vein walls in venous thrombosis. Scand J Haematol Suppl 1971; 16: 1–29.

De Cossart L Marcuson RW . A simple quantitative assay of tissue plasminogen activator. J Clin Pathol 1982; 35: 980–83.

De Cossart L Marcuson RW . Vascular plasminogen activator and deep vein thrombosis. Br J Surg 1983; 70: 369–70.

Smokovitis A Kokolis N Alexaki-Tzivanidou E. Fatty streaks and fibrous plaques in human aorta show increased plasminogen activator activity. Haemostasis 1988; 18: 146–53.

Reilly JM Sicard GA Lucore CL . Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg 1994; 19: 865–72.

Schneiderman J Sawdey MS Keeton MR Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992; 89: 6998–7002.

Padro T Steins M Hammel D Kienast J. Atherosclerosis-related alterations of the plasminogen activator/plasmin system in the vascular wall: Studies in human coronary arteries [Abstract]. Thromb Haemost 1993; 69: 971.

Lupu F Bergonzelli GE Heim DA Localization and production of plasminogen activator inhibitor 1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993; 13: 1090–100.

Chomiki N Henry M Alessi MC Anfosso F Juhan-Vague I. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb Haemost 1994; 72: 44–53.

Robbie LA Booth NA Brown PAJ Croll AM Bennett B. Localisation and quantification of proteins of the fibrinolytic system in normal and atherosclerotic vessels [Abstract]. Fibrinolysis 1994; 8 (suppl 1): 86.

Hamsten A Eriksson P. Fibrinolysis and atherosclerosis: An update. Fibrinolysis 1994; 8 (suppl 1): 253–62.

Van Hinsbergh VWM Kooistra T Emeis JJ Koolwijk P. Regulation of plasminogen activator production by endothelial cells: Role in fibrinolysis and local proteolysis. Int J Rad Biol 1991; 60: 261–72.

Kooistra T. The use of cultured human endothelial cells and hepatocytes as an in vitro model to study modulation of endogenous fibrinolysis. Fibrinolysis 1990; 4 (suppl 2): 33–39.

Kooistra T Schrauwen Y Arts J Emeis JJ . Regulation of endothelial cells t-PA synthesis and release. Int J Hematol 1994; 59: 233–55.

Levin EG Marzec U Anderson J Harker LA . Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest 1984; 74: 1988–95.

Hanss M Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: Modulation by thrombin, endotoxin and histamine. J Lab Clin Med 1987; 109: 97–104.

Van Hinsbergh VWM Sprengers ED Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 1987; 57: 148–53.

Levin EG Marotti KR Santell L. Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA. J Biol Chem 1989; 264: 16030–36.

Kooistra T Bosma PJ Toet K Role of protein kinase C and cAMP in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor 1 and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos. Arterioscler Thromb 1991; 11: 1042–52.

Levin EG Santell L. Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells. J Biol Chem 1988; 263: 9360–65.

Carter TD Pearson JD . Regulation of prostacyclin synthesis in endothelial cells. News Physiol Sci 1992; 7: 64–69.

Santell L Levin EG . Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. J Biol Chem 1988; 263: 16802–808.

Feng P Ohlsson M Ny T. The structure of the TATA-less rat tissue plasminogen activator gene. J Biol Chem 1990; 265: 2022–27.

Emeis JJ de Vries REM Schrauwen Y Kooistra T. Enhancement of endogenous rat plasma tissue-type plasminogen activator antigen and activity by cAMP-enhancing compounds [Abstract]. Fibrinolysis 1994; 8 (suppl 1): 21.

Kooistra T Opdenberg JP Toet K Hendriks HFJ van den Hoogen CM Emeis JJ . Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemost 1991; 65: 565–72.

Thompson EA Nelles L Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur J Biochem 1991; 201: 627–32.

Bulens F Nelles L van den Panhuyzen N Collen D. Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: Relations of structure to effect. J Cardiovasc Pharmacol 1992; 19: 508–14.

Medh RD Santell L Levin EG . Stimulation of tissue plasminogen activator production by retinoic acid: Synergistic effect on protein kinase C-mediated activation. Blood 1992; 80: 981–87.

Kooistra T. The potentials of retinoids as stimulators of endogenous tissue-type plasminogen activator. In: Glas-Greenwalt P ed. Fibrinolysis in disease. Boca Raton, FL: CRC Press, 1995 (in press).

Bulens F Thompson AE Stassen JM Induction of t-PA synthesis with intravenous bolus injections of vitamin A palmitate in vitamin A deficient rats. Fibrinolysis 1992; vmr-6: 243–49.

Van Bennekum AM Emeis JJ Kooistra T Hendriks HFJ . Modulation of tissue-type plasminogen activator by retinoids in rat plasma and tissues. Am J Physiol 1993; 264: R931–37.

Van Giezen JJJ Boon GDIA Jansen JWCM Bouma BN . Retinoic acid enhances fibrinolystic activity in vivo by enhancing tissue plasminogen activator (t-PA) activity and inhibits venous thrombosis. Thromb Haemost 1993; 69: 381–86.

Declerck PJ Boden G Degreef H Collen D. Influence of oral intake of retinoids on the human plasma fibrinolytic system. Fibrinolysis 1993; 7: 347–51.

Wallnöfer AE van Griensven JMT Schoemaker HC Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans. Thromb Haemost 1993; 70: 1005–1008.

Kooistra T Toet K Kluft C Triazolobenzodiazepines: A new class of stimulators of tissue-type plasminogen activator synthesis in human endothelial cells. Biochem Pharmacol 1992; 46: 61–67.

Kooistra T van den Berg J Töns A Platenburg G Rijken DC van den Berg E. Butyrate stimulates tissue-type plasminogen activator synthesis in cultured human endothelial cells. Biochem J 1987; 247: 605–12.

Diamond SL Eskin SG McIntyre LV . Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 1989; 243: 1483–85.

Iba T Shin T Sonoda T Rosales O Sumpio BE . Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stress. J Surg Res 1991; 50: 457–60.

Iba T Sumpio BE . Tissue plasminogen activator expression in endothelial cells exposed to cyclic strain in vitro. Cell Transplant 1992; 1: 43–50.

Santell L Marotti K Bartfeld NS Baynham P Levin EG . Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells. Exp Cell Res 1992; 201: 358–65.

Shatos MA Doherty JM Orfeo T Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J Biol Chem 1992; 267: 597–601.

Kugiyama K Sakamoto T Misumi I Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res 1993; 73: 335–43.

Levin EG Santell L Saljooque F. Hyperosmotic stress stimulates tissue plasminogen activator expression by a PKC-independent pathway. Am J Physiol 1993; 265: C387–96.

Kelly RB . Pathways of protein secretion in eukaryotes. Science 1985; 230: 25–32.

Sporn LA Marder VJ Wagner DD . Inducible secretion of large biologically potent von Willebrand factor multimers. Cell l 1986; 46: 185–90.

Reinders JH de Groot PG Sixma JJ van Mourik JA . Storage and secretion of von Willebrand factor by endothelial cells. Haemostasis 1988; 18: 246–61.

Wagner DD . Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990; vmr-6: 217–46.

Wagner DD . The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70: 105–10.

Schrauwen Y Emeis JJ Kooistra T. A sensitive ELISA for human tissue-type plasminogen activator applicable to the study of acute release from cultured human endothelial cells. Thromb Haemost 1994; 71: 225–29.

Schrauwen Y de Vries REM Kooistra T Emeis JJ . Acute release of tissue-type plasminogen activator (tPA) from the endothelium: Regulatory mechanisms and therapeutic target. Fibrinolysis 1994; 8 (suppl 2): 8–12.

Tranquille N Emeis JJ . Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasminogen activator. Thromb Haemost 1989; 61: 442–47.

Giles AR Nesheim ME Herring SW Hoogendoorn H Stump DC Heldebrant CM . The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemost 1990; 63: 476–81.

Padró T van den Hoogen CM Emeis JJ . Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues. Blood Coagulat Fibrinol 1990; 1: 601–608.

Emeis JJ van den Hoogen CM Schrauwen Y. An endothelial storage granule for tissue-type plasminogen activator [Abstract]. Thromb Haemost 1993; 69: 609.

Jern C Selin L Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 1994; 72: 285–91.

Jern S Selin L Bergbrant A Jern C. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Thromb Haemost 1994; 72: 588–94.

Emeis JJ . Mechanisms involved in short-term changes in blood levels of t-PA. In: Kluft C ed. Tissue-type plasminogen activator: Physiological and clinical aspects, volume 2. Boca Raton, FL: CRC Press, 1988: 21–35.

Emeis JJ . Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N York Acad Sci 1992; 667: 249–58.

Klöcking HP . Pharmakologische Beëinflussung der Freisetzung von t-PA aus dem Gefässendothel. Hämostaseologie 1991; 11: 76–88.

Tranquille N. Pharmacological modulation of the release of tissue-type plasminogen activator and von Willebrand factor [Thesis] O Leiden: University of Leiden, 1991.

Van den Eijnden-Schrauven Y Kooistra T de Vries REM Emeis JJ . Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: Evidence for a dynamic storage pool. Blood 1995; (in press).

Tranquille N Emeis JJ . The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost 1990; 63: 454–58.

Smalley DM Fitzgerald JE O'Rourke J. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs. Thromb Haemost 1993; 70: 1043–46.

Grant PJ . Hormonal regulation of the acute haemostatic response to stress. Blood Coagulat Fibrinol 1990; 1: 299–305.

Chandler WL Veith RC Fellingham GW Fibrinolytic response during exercise and epinephrine infusion in the same subjects. J Am Coll Cardiol 1992; 19: 1412–20.

Emeis JJ . Normal and abnormal endothelial release of tissue-type plasminogen activator. In Glas-Greenwalt P ed. Fibrinolysis in disease. Boca Raton, FL: CRC Press, 1995 (in press).

Keber D Blinc A Fettich J. Increase of tissue plasminogen activator in lilmbs during venous occlusion: A simple haemodynamic model. Thromb Haemost 1990; 64: 433–38.

De Boer A Kluft C Kroon MJ Liver blood flow as a major determinant of the clearance of recombinant tissue-type plasminogen activator. Thromb Haemost 1992; 67: 83–87.

Chandler WL Levy WC Stratton JR . The circulatory regulation of t-PA and u-PA during exercise and alpha and beta-adrenergic agonist infusion [Abstract]. Fibrinolysis 1994; 8 (suppl 1): 13.

Hashemi S Palmer DS Aye MT Gaz PR . Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells. J Cell Physiol 1993; 154: 496–504.

Loskutoff DJ Sawdey M Mimuro J. Type I plasminogen activator inhibitor. Prog Hemost Thromb 1989; 9: 87–115.

Dawson S Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 1992; 95: 105–17.

Juhan-Vague I Alessi MC . Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost 1993; 70: 138–43.

Juhan-Vague I Alessi MC Nalbone G. Fibrinolysis and atherothrombosis. Curr Opin Lipidol 1993; 4: 477–83.

Aznar J Estellés A. Role of plasminogen activator inhibitor type 1 (PAI-1) in the pathogenesis of coronary artery disease. Haemostatis 1994; 24: 243–51.

Rocha E Páramo JA . The relationship between impaired fibrinolysis and coronary heart disease; a role for PAI-1. Fibrinolysis 1994; 8: 294–303.

Simpson AJ Booth NA Moore NR Bennett B. Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol 1991; 44: 139–43.

Lucore CL Fugii S Wun TC Sobel BE Billadello JJ . Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem 1988; 263: 15845–48.

Whawell SA Wang Y Fleming KA Thompson EM Thompson JN . Localization of plasminogen activator inhibitor-1 production in inflamed appendix. J Pathol 1993; 169: 67–71.

Thornton AJ Gelehter TD . Human-hepatocytes express the gene for type 1 plasminogen activator–inhibitor (PAI-1) in vivo. Fibrinolysis 1995; 9: 9–15.

Suffredini AF Harpel PC Parrillo JE . Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320: 1165–72.

Sawdey M Loskutoff DJ . Regulation of type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α and transforming growth factor-β. J Clin Invest 1991; 88: 1346–53.

Sawa H Fujii S Sobel BE . Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis. Arterioscler Thromb 1992; 12: 1507–15.

Sawa H Sobel BE Fujii S. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type-1 by endothelial injury. Circ Res 1993; 73: 671–80.

Clowes AW Clowes MM Au YTP Reidy AM Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990; 67: 61–67.

Clowes AW Clowes MM Kirkman TR Jackson CL Au YPT Kenagy R. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res 1992; 70: 1128–36.

Jackson CL Raines EW Ross R Reidy MA . Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 1993; 13: 1218–26.

Jackson CL Reidy MA . Basic fibroblast growth factor: Its role in the control of smooth muscle cell migration. Am J Pathol 1993; 143: 1024–31.

Rosenfeld BA Beattie C Christophersen R Perioperative ischemia randomized anesthesia trial study group: The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Anesthesiology 1993; 79: 435–43.

Kluft C Verheijen JH Jie AFH The postoperative fibrinolytic shutdown: A rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45: 605–10.